Finance

Lists
Why is WQ5 down 2.27%?
Dive Deeper
WQ5:FRA
Genflow Biosciences PLC
€0.022
-2.27%
(-0.00050) 1D
Sep 30, 10:00:00 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for WQ5...
Open
€0.02
High
€0.02
Low
€0.02
Mkt. cap
11.80M
Avg. vol.
0.00
Volume
0.00
52-wk high
€0.04
52-wk low
€0.01
No. of employees
5
Open
€0.02
High
€0.02
Low
€0.02
Mkt. cap
11.80M
Avg. vol.
0.00
Volume
0.00
52-wk high
€0.04
52-wk low
€0.01
No. of employees
5
About Genflow Biosciences PLC
CEO-
Employees5
Founded2020
Headquarters-
SectorBiotechnology
Previous reportsAll values in GBP
Loading Previous Earnings...
Revenue
Net income
All values in GBP
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
-
-
292.80K
292.80K
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
-
555.24K
555.24K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
491.36K
491.36K
-45.57K
-45.57K
Operating expense
368.81K
368.81K
632.78K
632.78K
Total operating expenses
368.81K
368.81K
632.78K
632.78K
Operating income
-368.81K
-368.81K
-339.97K
-339.97K
Other non operating income
-
-
-
-
EBT including unusual items
-368.81K
-368.81K
-339.97K
-339.97K
EBT excluding unusual items
-368.81K
-368.81K
-339.97K
-339.97K
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-122.55K
-122.55K
122.55K
122.55K
Net income
-368.81K
-368.81K
-339.97K
-339.97K
Net profit margin
-
-
-116.11%
-116.11%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-
-
-
-
Net interest expenses
-
-
-
-
Depreciation and amortization charges
-
-
547.00
547.00
EBITDA
-368.51K
-368.51K
-339.72K
-339.72K
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google apps